To assess the efficacy of a β-galactomannan oligosaccharide (ß-GMOS) for the control of Salmonella infection in fattening pigs.
Introduction
In the European Union (EU) human salmonellosis is ranked as the second most important zoonoses transmitted through the consumption of food, after campylobacteriosis (EFSA 2014) . This infection has been mostly associated with the consumption of Salmonella-contaminated poultry-derived products (eggs, meat, etc.) and in a less extent to other meat products such as pork or pork-derived products (EFSA, 2012) .
During the last years, the implementation in the EU of national eradication programs for Salmonella in poultry has caused a major decline in the incidence of the human salmonellosis related to poultry and products thereof throughout Europe (EFSA 2014) , provoking a relative increase in the registered number of pork-related salmonellosis outbreaks, and emphasizing the need for programs to tackle this infection in pigs (Boyen et al. 2008) .
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Sampling scheme
All pigs were given in-feed colistin (120 ppm) for around two weeks right after arriving to the farm unit. After colistin, the treatment with the β-GMOS was initiated in the TG and serum was collected from all animals from both groups to check for possible significant differences in seroprevalence against Salmonella spp. at the beginning of the trial. At 60 and 90 days of the fattening period individual serum was collected again from all animals and fecal samples (Faecal Samples at the Farm -FSF-) were collected after spontaneous defecation from 20-25 pigs per group. In each sampling, pig from all the pens were sampled, with a minimum of 2 pigs/pen. One week before slaughter serum was collected from a minimum of 40 pigs in each group (except in the first trial, where sera could not be collected for logistic reasons). Mesenteric lymph nodes (MLN) and feces from distal colon (Faecal Samples at the Slaughter -FSS-) were collected at slaughter (after approximately 120 days of fattening) for a similar number of pigs, except for the first trial where only MLN were collected.
Because the inherent difficulties of collecting feces from rectum, slight variations in the number of sampled pigs with regard to the planned number of pigs to be sampled occurred. The exact number of animals analysed for each type of sample is shown in Tables 1 and 4 In order to establish the relationship between Salmonella isolates from MLN and feces (either FSF or FSS) and thus assess the effect of the β-GMOS on both the infection and further shedding, Salmonella
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Statistical analyses
Univariable chi-squared analysis was used to assess statistical differences in seroprevalence and shedding between the CG and the TG at the different point times considered, and in prevalence at slaughter. When low values or zeros were present the two-tailed Fisher exact test was used (EPI INFO 3.5.3., CDC, Atlanta, Georgia). A random-effects logistic regression (re-LG) with pen as the random factor was further performed to measure the overall effect that the use of the β-GMOS may have on the prevalence of infection and shedding at slaughter. The variable "Trial" was forced into the regression model as potential confounding factor (STATA/IC 12.1. StataCorp. LP, College Station, Texas).
Results
No relevant health-related problems were detected in any of the groups during the development of the field trials. Mortality rate was within the normal range (2-3%) for this farm for both groups for the three trials. No significant differences in seroprevalence were observed between the CG and the TG at the beginning of any of the three trials, thus groups were considered comparable.
Bacteriological results
The results on Salmonella spp. shedding (as indicated by fecal positive samples) and infection prevalence (MLN positive samples) for both the CG and the TG are presented in Table 1 . The prevalence of Salmonella spp. infection in the CGs was above 40% in the three field trials, and significantly higher in trial II (78.7%) compared to trials I and III (54.8% and 40.8%, respectively;
P<0.05).
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In Trial I, where the lowest dose of the β-GMOS (0.5 kg t -1 ) was used, no significant differences were observed between TG and CG at any sampling time. However, at higher doses (2 and 3 kg t -1 ) both the prevalence of infection (i.e. proportion of pigs with Salmonella in MLN) and shedding at slaughter were significantly lower in the TG than in the CG.
When the overall effect of the β-GMOS on Salmonella infection and shedding was estimated by the re-LG logistic regression using combined results from all the trials at slaughter, and after adjusting by trial and taking into account the pig allocation to pens (random factor), doses of 2 or 3 kg t -1 of β-GMOS decreased significantly (P<0.01) the prevalence of infection and shedding (Table 2) . A higher reduction was observed when a higher dose was used.
Strain characterization
Out of 198 strains of Salmonella isolated, only 149 (75%) were serotyped due to budget restrictions.
All the non-serotyped strains corresponded to isolates from the CGs from trials II and III, as they were the groups presenting a larger number of isolates. At least 70% of the isolates from each of these two groups were serotyped (Table 3) .
Most (53%) of the serotyped isolates corresponded to the monophasic variant of Typhimurium (4, [5] ,12:i:-), followed by Typhimurium (17.4%), Rissen (16.8%), Goldcoast (6%) and other (6.7%) less prevalent serotypes. The distribution of strain serotypes by trial and type of sample is presented in 
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changing room, no footbaths or boots for visitors available, etc.). Under these field conditions we ensured the exposure of all pigs to the same naturally Salmonella-contaminated environment while half of them were also exposed to a constant concentration of the β-GMOS through the feed. Initially, a low dose (0.5 kg t -1 of feed) of β-GMOS was used as it had shown some antimicrobial effects in experimental studies on poultry (manufacturer personal communication). In this first trial, infection at MLN was the main outcome of interest and no fecal or serum samples were collected at slaughter. No significant effect was however observed on Salmonella infection at slaughter, neither on fecal shedding at the farm. These results could be explained by the large differences expected between poultry and pigs regarding intestinal physiology, amount of feed ingested, etc. In contrast, when the dose of β-GMOS was considerably increased (trials II and III), a significant reduction in the proportion of Salmonella -infected (i.e. positive in MLN), -shedding and -seropositive (trial II) pigs at slaughter was observed in TGs respect to the corresponding CGs. In fact, the addition of ≥2 kg t -1 of β-GMOS during the entire growing period was able to decrease the prevalence of Salmonella infection at slaughter to 0% in trial II and to less than 6% in trial III (Table 1) . A similar finding was observed regarding Salmonella shedding at slaughter, which was reduced to 2.6% in trial II and to 11.8% in trial III (Table 1) , while a significant reduction in seroconversion was only evidenced with the highest β-GMOS dose used (Table 4) .
At farm level, no differences in Salmonella shedding during the growing period were observed between the CG and the TG for any of the trials. However, factors such as the intermittent shedding of these bacteria over time (Pires et al. 2013) , the lack of sensitivity of the microbiological technique when performed on fecal samples from asymptomatic pigs (Hurd et al. 2004; Mainar-Jaime et al. 2008a) , and the limited number of animals analyzed in each group, may have hindered the detection of significant differences in shedding between
This article is protected by copyright. All rights reserved. The results from the re-LG showed a clear decreasing trend in the prevalence of infection (i.e.
Salmonella in MLN) at slaughter when the dose of β-GMOS increased from 2 to 3 kg t -1 of feed, in trials III and II, respectively. According to these results, the overall efficacy of β-GMOS in these field trials, measured as the preventive fraction (1-Odds Ratio), could reach from 91% (when a 2 kg t -1 dose was used) up to 99.2% (3 kg t -1 ) when compared to the group composed by all control pigs from the trials. A similar decreasing trend would be expected on shedding, according to results shown in Table 2 . Bearing in mind that the proportion of carrier pigs at slaughter could likely be considered a proxy of the Salmonella contamination arriving to the slaughter line (Berends et al. 1997) , the addition of this β-GMOS may have contributed to decrease significantly the risk of Salmonella contamination of the carcasses.
The PFGE analysis revealed that, within a trial, some strains of S. Typhimurium and S.
Rissen that had been previously isolated from faeces at the farm were later found in MLN from control pigs at the slaughter (Figure 1 ), supporting this conclusion. It is worth to mention that a few pigs (5 in trial II and 2 in trial III) shed at some point Salmonella strains different from those isolated from their MLN (Figure 1 ), which would support the presence of simultaneous infections by different Salmonella strains in a single pig, as it has been recently described elsewhere (Garrido et al. 2014) .
This article is protected by copyright. All rights reserved. The positive effect of this β-GMOS on the control of Salmonella infection was further supported by the significant lower number of pigs seroconverting in the TG compared to the CG in trial II. In trial III, however, no differences were observed, as the proportion of pigs seroconverting was very low in both groups. This low level of seroconversion could be attributed to a late infection, either at the end of the fattening period, or even during transport to the slaughter or at lairage, as at least seven days are usually required to detect specific antibodies against Salmonella spp. ( Nielsen et al. 1995; Scherer et al. 2008) . In fact, 85% of the strains from this trial were isolated once the pigs arrived to the slaughter. The lack of seroconversion could also be related with the delayed onset of seroconversion showed by certain Salmonella strains that show higher faecal shedding and an increased persistence (Van Parys et al. 2013) . The unexpected but non-significant difference in seroprevalence between CG and TG in this trial (0% vs. 7.8%, respectively) was most likely due to the intrinsic variability of the ELISA used, as three animals from the CG had high %ODs (>36%) but lower than the 40% required to be deemed test negative.
A matter of concern derived from this study was the high level of AR observed. All
Salmonella strains analyzed showed some type of multi AR. Since the origin of most isolates could not be traced to this farm, particularly the S. 4, [5] ,12:i:-strains, these results would reflect the overall increasing trend in AR for pig-related Salmonella strains.
In view of the bacteriological results observed, this β-GMOS seemed to be effective against Salmonella infection in fattening pigs when a dose ≥2 kg t -1 of feed was used for the entire period of growing. Its use during the whole period of fattening was the consequence of the lack of knowledge regarding the time of higher risk of Salmonella exposure in this growing unit. A good knowledge of the dynamics of Salmonella infection in the farm may allow for the definition of the best periods of application, thus reducing its cost. Overall, feed supplementation with this β-GMOS could be considered a useful complementary tool for the control of pig salmonellosis, along with good hygiene and farm biosecurity practices.
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